Differing chemotherapies and their effects in the treatment of mCRPC

The results of two recent, large clinical trials may have some impact on the clinical use of cabazitaxel (Jevtana) in the treatment of late-stage prostate cancer. … READ MORE …

Don’t docetaxel and drive!

Every so often one learns something quite unexpected that one probably should have been aware of previously. This is salutary … but it is also a good thing! … READ MORE …